PARIET

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Spain, Finland, France, Hong Kong, Ireland, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug PARIET contains one active pharmaceutical ingredient (API):

1 Rabeprazole UNII 3L36P16U4R - RABEPRAZOLE SODIUM

Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump). Read about Rabeprazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PARIET Gastro-resistant tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A02BC04	Rabeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11670F, 12286P, 8507R, 8508T, 8509W
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514503301118214, 514503304117219, 514503305113217, 514503306111218, 514512110026303, 514516020032203
Country: CA	Health Products and Food Branch	Identifier(s): 02243796, 02243797
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00176578, 00176584, 00176590, 00176621, 00176638, 00176644, 03743339, 03743345, 13981904, 16206270
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 034216186-M, 039351010, 3400935514790, 355147-9, 355147-9IP, 62461, 62462
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 065083, 108780, 378482, 514346, 551879, 557015, 568238
Country: FR	Base de données publique des médicaments	Identifier(s): 62909137, 66035518
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139447, 139449, 175884, 196973, 198588, 20088, 20094
Country: HK	Department of Health Drug Office	Identifier(s): 44935, 44936
Country: IE	Health Products Regulatory Authority	Identifier(s): 38811, 38825, 38868, 38920
Country: IT	Agenzia del Farmaco	Identifier(s): 034216022, 034216186
Country: JP	医薬品医療機器総合機構	Identifier(s): 2329028F1023, 2329028F2020, 2329028F3026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1021251, 1021252, 1021253, 1021254
Country: MT	Medicines Authority	Identifier(s): MA018/01901, MA018/01902, PI521/07404A, PI770/17301A, PI908/07701A, PI908/07702A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 505M98
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 54860, 54879
Country: SG	Health Sciences Authority	Identifier(s): 11232P, 11233P, 15531P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593045295
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/11.4.3/0614, 33/11.4.3/0206